21.12.2007 09:20 Uhr, Beauty/Wellness/ Gesundheit, Fresenius AG (SE)

Fresenius Biotech applies for the marketing authorization of the trifunctional antibody Removab® for the treatment of malignant ascites

Fresenius Biotech has dispatched the marketing authorization application for the trifunctional antibody Removab (INN: catumaxomab) in patients with malignant ascites...

weiter »

23.12.2008 08:55 Uhr, Beauty/Wellness/ Gesundheit,

Phase II study shows trifunctional antibody Removab® (catumaxomab) well tolerated in treatment of gastric cancer

A Phase II study with the trifunctional antibody catumaxomab in the treatment of patients with gastric cancer showed the antibody was well tolerated. The primary...

weiter »

24.02.2010 13:11 Uhr, Geld/Finanzen/ Versicherungen,

Record financial results in 2009 / All financial targets met or exceeded / Positive outlook for 2010

. - Sales €14.2 billion, +15% at actual rates, +13% in constant currency - EBIT €2.1 billion, +19% at actual rates, +17% in constant currency - Adjusted net income(1)...

weiter »

23.04.2009 09:35 Uhr, Beauty/Wellness/ Gesundheit,

Fresenius Biotech receives approval for Removab® by European Commission - First Drug worldwide for Treatment of Malignant Ascites

The European Commission has approved Removab (catumaxomab) for the treatment of malignant ascites with immediate effect. It is the first drug worldwide with a regulatory...

weiter »

18.02.2009 09:08 Uhr, Beauty/Wellness/ Gesundheit,

EMEA-Committee for Medicinal Products for Human Use issues positive opinion for Removab® (catumaxomab) for the treatment of malignant ascites

The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval of Removab for...

weiter »

30.07.2008 09:10 Uhr, Geld/Finanzen/ Versicherungen,

First half 2008: Strong financial results

. - Sales € 5.7 billion, +2 % at actual rates, +9 % in constant currency - EBIT € 781 million, +0 % at actual rates, +8 % in constant currency - Net income €...

weiter »

31.10.2007 09:42 Uhr, Geld/Finanzen/ Versicherungen, Fresenius AG (SE)

Excellent sales and earnings growth in all business segments – Strong third quarter – Outlook raised

Diese Pressemitteilung wurde als Adobe PDF Datei eingestellt. Sie benötigen den Adobe Acrobat Reader um die Pressemitteilung anzuzeigen.

weiter »

02.08.2007 09:36 Uhr, Geld/Finanzen/ Versicherungen, Fresenius AG (SE)

First half 2007

Diese Pressemitteilung wurde als Adobe PDF Datei eingestellt. Sie benötigen den Adobe Acrobat Reader um die Pressemitteilung anzuzeigen.

weiter »